Global Ventriculo-Peritoneal Hydrocephalus Shunts Market – Industry Trends and Forecast to 2029

Global Ventriculo-Peritoneal Hydrocephalus Shunts Market, By Product Type (Hydrocephalus Valves, Hydrocephalus Catheters), Age Group (Pediatric, Adult), End-User (Hospitals, Ambulatory Surgical Centers) – Industry Trends and Forecast to 2029

Ventriculo-Peritoneal Hydrocephalus Shunts Market Analysis and Size

The market for ventriculo-peritoneal hydrocephalus shunts is anticipated to grow during the forecast period from 2022 to 2029. The market is primarily driven by an increase in the number of hydrocephalic patients around the world. For instance, the National Institute of Neurological Disorders and Stroke estimates that 1 to 2 of every 1000 kids will be born worldwide in 2020 with hydrocephalus. As a result, given the overall number of births each year, the prevalence of hydrocephalus is expected to rise in the coming years.

Data Bridge Market Research analyses that the ventriculo-peritoneal hydrocephalus shunts market which was USD 412.6 million in 2021, would rocket up to USD 600.37 million by 2029, and is expected to undergo a CAGR of 4.80% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Shunts for hydrocephalus are medical devices used to treat a disease where fluid accumulates in the brain and causes a rise in intracranial pressure. It is frequently offered in variations with catheters, adjustable pressure valves, fixed pressure valves, and valves. It is a flexible tube inserted into the brain region responsible for producing cerebrospinal fluid (CSF). A hydrocephalus shunt consists of an outflow or distal catheter that passes under the skin and directs CSF, an inflow or proximal catheter that drains CSF from the lateral ventricles, and a valve mechanism that regulates intracranial pressure by controlling fluid flow. It helps to reduce stress on the brain and shrink the enlarged ventricles of the brain back to their normal size.

Ventriculo-Peritoneal Hydrocephalus Shunts Market Dynamics

Drivers

• Rise in neurological diseases

The main factors fuelling the market's expansion is the rising frequency of brain and neurological illnesses among the general population. Due to the increased prevalence of congenital anomalies, brain and nerve traumas, accidents resulting in central nervous system (CNS) problems, and lifestyle conditions, hydrocephalus shunts are frequently employed. The market is also benefiting from the rising product demand to treat baby hydrocephalus, which can cause the head to swell and harm the brain.

• Technological developments

The market is growing as a result of technological developments, including the creation of anti-siphon devices that help prevent syphon effects over cerebrospinal fluid. Accordingly, the creation of programmable valves to manage cerebrospinal fluid flow and prevent it from flowing in the wrong direction is favorably affecting market expansion. Other factors are projected to propel the market toward global expansion, including significant growth in the healthcare sector and the deployment of several government efforts to raise awareness about hydrocephalus shunts.

Opportunities

• Increase in prevalence of disorders

The ventriculo-peritoneal hydrocephalus shunts the market's growth is fuelled by the increasing prevalence of brain and neurological disorders among the masses. This will provide beneficial opportunities for the ventriculo-peritoneal hydrocephalus shunts market growth.

Moreover, increase in the number of emerging markets and new product launches will further provide beneficial opportunities for the ventriculo-peritoneal hydrocephalus shunts market growth during the forecast period.

Restraints/Challenges

On the other hand, the issues concerning the contaminations caused by the utilization of hydrocephalus shunts and over seepage of cerebrospinal liquid will obstruct the market's growth rate. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the ventriculo-peritoneal hydrocephalus shunts market.

This ventriculo-peritoneal hydrocephalus shunts market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the ventriculo-peritoneal hydrocephalus shunts market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Ventriculo-Peritoneal Hydrocephalus Shunts Market

Every sector of the economy has been affected by the nationwide lockdowns brought by the COVID-19 epidemic. Likewise, the pandemic has an impact on the market for ventriculo-peritoneal hydrocephalus shunts. Due to COVID-19, the hydrocephalus shunts business is currently dealing with newer difficulties in keeping up with demand and supply. The market expansion is also anticipated to be impacted by uneven and interrupted supply chain operations and a lack of human resources. Neurological units and clinics were shut down worldwide as a result of the pandemic's abrupt outbreak. Due to the large number of COVID-19 patients, hospitals at the time ran out of supplies. As a result, the majority of neurosurgeons were transferred to COVID-19 wards, worsening access inequities for patients with hydrocephalus.

Global Ventriculo-Peritoneal Hydrocephalus Shunts Market Scope

The ventriculo-peritoneal hydrocephalus shunts market is segmented on the basis of product type, age group and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Hydrocephalus Valves
• Adjustable Pressure Valves
• Fix Pressure Valves
• Hydrocephalus Catheters

 Age Group

• Pediatric
• Adult

 End-User

• Hospitals
• Ambulatory Surgical Centers

Ventriculo-Peritoneal Hydrocephalus Shunts Market Regional Analysis/Insights

The ventriculo-peritoneal hydrocephalus shunts market is analysed and market size insights and trends are provided by country, product type, age group and end-user as referenced above.

The countries covered in the ventriculo-peritoneal hydrocephalus shunts market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the ventriculo-peritoneal hydrocephalus shunts market attributed to higher hydrocephalus prevalence rate, well-developed healthcare infrastructure, and favorable government reimbursement policies.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the higher number of pediatric population suffering from the disease.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The ventriculo-peritoneal hydrocephalus shunts market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for ventriculo-peritoneal hydrocephalus shunts market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the ventriculo-peritoneal hydrocephalus shunts market. The data is available for historic period 2010-2020.

Competitive Landscape and Ventriculo-Peritoneal Hydrocephalus Shunts Market Share Analysis

The ventriculo-peritoneal hydrocephalus shunts market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to ventriculo-peritoneal hydrocephalus shunts market.

Some of the major players operating in the ventriculo-peritoneal hydrocephalus shunts market are:

• Boston Neurosciences (U.S.)
• TKB Corporation (Japan)
• HLL Lifecare Limited (India)
• Christoph Miethke GmbH & Co. KG (Germany)
• Integra LifeSciences (U.S.)
• Sophysa SA (France)
• Spiegelberg GmbH & Co. KG (Germany)
• Terumo Corporation (Japan)
• Natus Medical Incorporated (U.S.)
• Braun Melsungen AG (Germany)
• Medtronic (Ireland)
• Johnson & Johnson Services Inc. (U.S.)
• HpBio Próteses, Inc. (U.S.)
• Kaneka Medix Corporation (Japan)